Alcohol Dependence Clinical Trial
Cognitive-behavioral therapy (CBT) is an effective treatment for alcohol dependence, but
little is known about how CBT works to achieve these effects. Although several possible
mechanisms have been proposed to explain the effects of CBT, it is rare that more than one
mechanism is studied. However, it may be the case that similar outcomes (e.g., abstinence)
may be reached through multiple paths. Therefore, essential to conducting work on behavioral
change mechanisms is distinguishing different courses or paths and moderating influences
(Kazdin, 2007). In the present study, we will focus on 2 key mechanisms posited to underlie
the effectiveness of CBT specifically, increasing self-efficacy and self-confidence and
reducing positive outcome expectancies for alcohol use, and 2 key mechanisms posited to
underlie the effectiveness of a wide range of therapeutic interventions, increasing the
therapeutic alliance and reducing/regulating negative emotional states. For the present
study, participants will be 72 alcohol dependent men and women who agree to participate in a
12-week trial of CBT for alcohol dependence. In addition, comprehensive research assessments
will be conducted with patients at baseline, end of treatment, and 3-months posttreatment.
Specific Aim 1. To examine the within-treatment week-to-week relationship between ratings of
4 key therapeutic mechanisms and alcohol involvement (operationalized as percent days
abstinent {PDA} and drinks per drinking day {DDD}) during treatment. It is hypothesized that
self-efficacy, outcome expectancies, therapeutic alliance (as rated by the patient and
therapist), and negative affect assessed after any given treatment session will each predict
alcohol involvement during the following week. Exploratory analyses also will investigate
the relationship of a given week's alcohol involvement on each of the four key variables as
assessed the following week.
Specific Aim 2. To examine profiles of the four key mechanisms over the course of treatment
in relation to alcohol involvement during treatment and during the 3-month follow-up period.
These analyses will be descriptive/exploratory. It is expected that profiles will emerge
with the key mechanisms that are associated with decreased alcohol involvement (for example,
when the alliance is relatively strong throughout treatment or when the alliance grows
stronger over the course of treatment, or when positive outcome expectancies grow weaker
over the course of treatment, etc.). Similarly, it is hypothesized that profiles will emerge
that are associated with little improvement in alcohol involvement (for example, when
negative affect is relatively high throughout treatment or when self-efficacy weakens over
the course of treatment).
n/a
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03340051 -
Remote Alcohol Monitoring and Episodic Thinking
|
N/A | |
Completed |
NCT02901041 -
Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism
|
Phase 3 | |
Not yet recruiting |
NCT06444243 -
Psilocybin-assisted Therapy for Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02705898 -
Lifestyle Physical Activity Intervention for Depressed Alcohol Dependent Women
|
N/A | |
Completed |
NCT02486900 -
Neurofeedback & Alcohol Dependence
|
N/A | |
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02197598 -
Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use
|
Phase 4 | |
Recruiting |
NCT02385643 -
The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients
|
N/A | |
Completed |
NCT01828866 -
Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients
|
N/A | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Active, not recruiting |
NCT01182766 -
New Treatment for Alcohol and Nicotine Dependence
|
Phase 2/Phase 3 | |
Completed |
NCT01342549 -
Treatment Strategy for Alcohol Use Disorders in Veterans With TBI
|
Phase 3 | |
Completed |
NCT02193204 -
Chronic Alcohol, Stress Inflammatory Response and Relapse Risk
|
N/A | |
Completed |
NCT01165541 -
A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency
|
Phase 2 | |
Completed |
NCT01176591 -
HBPL Study of the Impact of the NK1 Antagonist Aprepitant
|
Phase 2 | |
Completed |
NCT01056484 -
Mindfulness Meditation for Health
|
Phase 2 | |
Completed |
NCT00585780 -
Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse
|
Phase 1/Phase 2 | |
Completed |
NCT00607620 -
Disseminating Organizational SBI Services at Trauma Centers
|
N/A | |
Completed |
NCT00884884 -
Aripiprazole and Topiramate on Free-Choice Alcohol Use
|
Phase 2/Phase 3 | |
Completed |
NCT00463346 -
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
|
Phase 3 |